A study on efficacy of autonomic nerve regulating agents on manifestation of accessory pathway in paroxysmal supraventricular tachycardia patients

A study on efficacy of autonomic nerve regulating agents on manifestation of accessory pathway in paroxysmal supraventricular tachycardia patients - Importance of autonomic nerve regulating agents in paroxysmal supraventricular tachycardia patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030753

Enrollment

Registered

2018-01-11

Start date

2018-01-15

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal supraventricular tachycardia (PSVT)

Interventions

Landiolol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: A) Patients who have allergy for landiolol. B) Patients who have contraindications for beta blocker (uncontrolled bronchial asthma, shock, coronary spastic angina, peripheral artery disease). C) Patients with heart rate of 40 times/min or less D) Patients with low left ventricular function (left ventricular ejection fraction: 25% or less). E) Patients who are not willing to participate in the study.

Design outcomes

Primary

Measure	Time frame
Effective refractory period of and conduction time of accessory pathway.	—

Countries

Japan

Contacts

Public ContactIwaya Tomomi

Hirosaki University Graduate School of Medicine Department of Advance Management of Cardiac Arrhythmias

iwaya0713@hirosaki-u.ac.jp0172-39-5144

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026